Horien Biochemical Technology Co (ROCO:7814) Stock Based Compensation: NT$0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
19 GF Score
Price NT$30.15
! 1 Warning Sign
View Full Analysis

What is Horien Biochemical Technology Co Stock Based Compensation?

Horien Biochemical Technology Co ROCO:7814 +0.50% 19 Stock Based Compensation is NT$0.00 Mil as of Mar. 2026. GuruFocus rates ROCO:7814 with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Horien Biochemical Technology Co's Stock Based Compensation for the three months ended in Mar. 2026 was NT$0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was NT$0.00 Mil.

Horien Biochemical Technology Co Stock Based Compensation Related Terms

Horien Biochemical Technology Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co Stock Based Compensation Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
0.00 0.00 0.16 0.00

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7814
19GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

What does a Stock Based Compensation of NT$0.00 Mil mean?
Horien Biochemical Technology Co (ROCO:7814) has a Stock Based Compensation of NT$0.00 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Horien Biochemical Technology Co and its competitors.
Is Horien Biochemical Technology Co's Stock Based Compensation too high?
Horien Biochemical Technology Co's current Stock Based Compensation is NT$0.00 Mil. Overall, Horien Biochemical Technology Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Stock Based Compensation compare to VRTX and REGN?
Horien Biochemical Technology Co's Stock Based Compensation of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Horien Biochemical Technology Co and its competitors. Horien Biochemical Technology Co's current Stock Based Compensation is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Stock Based Compensation of NT$0.00 Mil. The current Stock Based Compensation is NT$0.00 Mil. Horien Biochemical Technology Co's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Stock Based Compensation is NT$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
19GF Score

Get the complete analysis for ROCO:7814

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.15
Price